Zevra Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	23.61	27.46	10.16	28.65	13.29	Upgrade
Revenue Growth (YoY)	-14.02%	170.26%	-64.53%	115.61%	3.50%	Upgrade
Cost of Revenue	7.42	2.17	0.22	2.06	1.31	Upgrade
Gross Profit	16.2	25.29	9.94	26.59	11.98	Upgrade
Selling, General & Admin	54.92	35.09	15.61	9.23	8.44	Upgrade
Research & Development	42.04	39.03	19.23	9.64	8.32	Upgrade
Operating Expenses	103.2	74.89	34.84	18.86	16.76	Upgrade
Operating Income	-87	-49.6	-24.9	7.73	-4.78	Upgrade
Interest Expense	-7.35	-1.5	-0.34	-0.38	-7.09	Upgrade
Interest & Investment Income	2.18	4.54	1.51	0.26	0.09	Upgrade
Other Non Operating Income (Expenses)	2.06	-0.1	15.16	-0.03	-0.18	Upgrade
EBT Excluding Unusual Items	-90.12	-46.66	-8.57	7.59	-11.97	Upgrade
Merger & Restructuring Charges	-	-	-	-	-0.83	Upgrade
Gain (Loss) on Sale of Investments	-0.02	0.61	-0.58	-0.01	-	Upgrade
Other Unusual Items	-	-	-	-16.1	-	Upgrade
Pretax Income	-90.14	-46.05	-26.81	-8.52	-12.79	Upgrade
Income Tax Expense	15.37	-	-0.03	0.03	-0.03	Upgrade
Net Income	-105.51	-46.05	-26.77	-8.56	-12.76	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	54.34	-	Upgrade
Net Income to Common	-105.51	-46.05	-26.77	-62.9	-12.76	Upgrade
Shares Outstanding (Basic)	46	35	34	30	4	Upgrade
Shares Outstanding (Diluted)	46	35	34	30	4	Upgrade
Shares Change (YoY)	30.46%	2.79%	15.87%	647.72%	114.79%	Upgrade
EPS (Basic)	-2.28	-1.30	-0.78	-2.11	-3.21	Upgrade
EPS (Diluted)	-2.28	-1.30	-0.78	-2.11	-3.21	Upgrade
Free Cash Flow	-69.67	-33.83	-18.81	10.34	-1.97	Upgrade
Free Cash Flow Per Share	-1.51	-0.95	-0.55	0.35	-0.49	Upgrade
Gross Margin	68.59%	92.09%	97.81%	92.81%	90.18%	Upgrade
Operating Margin	-368.47%	-180.63%	-245.07%	26.98%	-35.98%	Upgrade
Profit Margin	-446.85%	-167.69%	-263.48%	-219.54%	-96.03%	Upgrade
Free Cash Flow Margin	-295.04%	-123.20%	-185.12%	36.08%	-14.84%	Upgrade
EBITDA	-80.61	-48.6	-23.96	7.99	-4.51	Upgrade
EBITDA Margin	-	-176.97%	-235.78%	27.87%	-33.92%	Upgrade
D&A For EBITDA	6.39	1.01	0.94	0.26	0.27	Upgrade
EBIT	-87	-49.6	-24.9	7.73	-4.78	Upgrade
EBIT Margin	-	-180.63%	-245.07%	26.98%	-35.98%	Upgrade

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q